Contact
QR code for the current URL

Story Box-ID: 1251797

Infrareal Holding GmbH & Co. KG Emil-von-Behring-Str. 76 35041 Marburg, Germany http://www.infrareal.de
Contact Mr Christoph Hesse +49 6421 396228
Company logo of Infrareal Holding GmbH & Co. KG

Infrareal takes over Takeda’s pharmaceutical and biotech site in Orth

Marburg, Germany, 2nd June 2025 – Infrareal Holding GmbH & Co. KG today announced the completion of its acquisition of the pharmaceutical and biotech site in Orth, Lower Austria.

(PresseBox) (Marburg, )
  • The acquisition of the Orth pharmaceutical and biotech site represents a significant milestone in Infrareal Group’s expansion strategy.
  • PharmaparkOrth Management GmbH will become the owner and operator of the pharmaceutical and biotech site in Austria as a subsidiary of Infrareal Holding GmbH & Co. KG.
  • As of 31 May 2025, Infrareal will take over more than 30 employees at the site, whose expertise will ensure the reliable continuation of operations and drive further development and expansion.
Through its subsidiary PharmaparkOrth Management GmbH, Infrareal is acquiring the 24-hectare site from Takeda including buildings, infrastructure and several pharmaceutical production facilities. The agreement was signed by both companies in November 2024.

The acquisition represents a significant advancement in Infrareal Group’s strategy to establish itself as one of Europe’s leading operators of pharmaceutical and life science parks. “I am very grateful and proud of my colleagues, who have put in many months of hard work together with the Takeda team. The successful conclusion of this transaction marks a milestone in our company’s history”, says Dr Martin Egger, CEO and spokesman of the Infrareal Management Board.

At the Pharma Park in Orth, the existing buildings and facilities will be supplemented by the development and marketing of open areas to enable further growth. Conversations with several companies interested from the biotechnology sector are in progress already. Through synergies and innovative infrastructure solutions, Infrareal creates opportunities for optimisation and growth at all its sites. This enables long-term prospects for companies in the pharmaceutical, biotech, and life science sectors.

“We look forward to working with the Infrareal Group. As owner and operator, they have a clear goal of further developing the Orth site, creating synergies and continuing to promote sustainable processes and decarbonisation”, says Christian Froeschl-Drahos, Site Quality Lead at Takeda in Orth.

Orth is an attractive location for international biopharmaceutical companies thanks to its facilities and infrastructure, highly qualified workforce and proximity to Vienna International Airport and the Austrian capital.
Alongside Takeda, another major international pharmaceutical company, Pfizer Manufacturing GmbH, is located at the site. “We are pleased with the Infrareal Group’s decision to invest at this site. It shows that they are  as well convinced of the great potential of the Orth pharmaceutical and biotech site, which will further strengthen our region”, says Elisabeth Wagnes, Mayor of Orth, who was unable to welcome the new owners in person. Josef Drabits, Deputy Mayor of Orth, represented her and took the opportunity to get to know the site and its employees.

Contact for enquiries
Infrareal Holding GmbH & Co.KGKerstin von Heemskerck
Director Corporate Communications & Marketing
Email: http://mailto:kerstin.vonheemskerck@infrareal.de

Infrareal Holding GmbH & Co. KG

Infrareal Holding is a management holding company and leading group of site operators specialising in the operation and development of industrial and business parks, with a focus on pharmaceuticals and life science. The company is owned by Swiss Life Asset Management AG and Gelsenwasser AG and pursues a one-company approach, offering clients an extensive range of services in the areas of professional management, infrastructure, technology, and logistics from a single source.

With many years of experience, Infrareal operates successful pharmaceutical and life science parks in Europe with over 800 employees, supporting more than 7,500 people working at these sites. The company’s philosophy includes transparent pricing models and customised services as well as a commitment to employee development. As the owner and operator of the sites, Infrareal makes long-term investments while continuing to grow and strive for the highest customer satisfaction.

www.infrareal.de

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2025, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.